IFNA is released by almost all cell types and a few of its family members, specifically human IFNA2a and IFN2b, are currently approved for treatment of a range of viral diseases including hepatitis B and C, condylomata acuminate (genital warts), and AIDS-related Kaposi sarcoma [15]. Here, IFNA2 is linked to Kaposi's sarcoma.